Inventor
VIRANI ANISA NIZARALI
GB13 patents
⚠️ This page may combine multiple inventors who share the name “VIRANI ANISA NIZARALI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
VERTEX PHARMA
9 patentsUS9701674B2Jul 11, 2017
Substituted pyrazines as ATR kinase inhibitors
VERTEX PHARMA22 citations94
US9365557B2Jun 14, 2016
Substituted pyrazin-2-amines as inhibitors of ATR kinase
VERTEX PHARMA27 citations94
US10961232B2Mar 30, 2021
Substituted pyrazines as ATR kinase inhibitors
VERTEX PHARMA2 citations73
US12247021B2Mar 11, 2025
Substituted tetrahydrofurans as modulators of sodium channels
VERTEX PHARMA1 citations72
US11834441B2Dec 5, 2023
Substituted tetrahydrofurans as modulators of sodium channels
VERTEX PHARMA4 citations72
US10479784B2Nov 19, 2019
Substituted pyrazin-2-amines as inhibitors of ATR kinase
VERTEX PHARMA3 citations72
US11919887B2Mar 5, 2024
Substituted tetrahydrofurans as modulators of sodium channels
VERTEX PHARMA2 citations71
US11827627B2Nov 28, 2023
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
VERTEX PHARMA3 citations71
US12258333B2Mar 25, 2025
N-(hydroxyalkyl (hetero)aryl) tetrahydrofuran carboxamides as modulators of sodium channels
VERTEX PHARMA0 citations60
CHARRIER JEAN-DAMIEN
4 patentsUS8410112B2Apr 2, 2013
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN56 citations93
US9062008B2Jun 23, 2015
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN14 citations84
US8623869B2Jan 7, 2014
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN20 citations84
US9334244B2May 10, 2016
Compounds useful as inhibitors of ATR kinase
CHARRIER JEAN-DAMIEN12 citations83